| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dogwood Therapeutics, Inc. (DWTX) has 9 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. DWTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 460.0K | $759.0K | - | |
| CFO | 150.0K | $247.5K | - | |
| VP | 150.0K | $247.5K | - | |
| Other | 150.0K | $247.5K | - | |
| ? | 2.4K | $3.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2021 | Duncan Gregory Scott | Chief Executive Officer | Buy | 382 | $6.36 | $2,428.60 | +2.0% | +5.0% | -24.4% | |
| Apr 5, 2021 | Duncan Gregory Scott | Chief Executive Officer | Buy | 15,675 | $6.17 | $96,757.07 | +401.5% | +1.0% | -25.5% | |
| Jan 29, 2021 | Pridgen William | Director | Buy | 3,500 | $7.47 | $26,145.00 | New | - | - | |
| Jan 28, 2021 | Walsh Angela | VP Of Finance | Buy | 1,000 | $7.30 | $7,300.00 | New | - | - | |
| Dec 17, 2020 | Pridgen William | Director | Buy | 1,500 | $11.98 | $17,970.00 | +0.2% | - | - |